Escherichia coli O157:H7 is a commensal organism in cattle, but it is a pathogen in humans. This differential expression of virulence suggests that specific virulence factors are regulated differently in human and bovine hosts. To test this hypothesis, relative real-time reverse transcription-PCR was used to relate the expression of several putative virulence genes (eae, espA, stx 2 , rfbE, ehxA, and iha) to that of the "housekeeping" gene gnd during natural human and experimental bovine infection with E. coli O157:H7. We examined these genes in fecal samples from eight humans and four calves. iha and espA were significantly more expressed in bovine infections. rfbE and ehxA appeared to be more highly expressed in human infections, though these differences did not achieve statistical significance. Our results support the hypothesis that some virulence-associated genes of O157:H7 are differentially expressed in a host-specific manner.Escherichia coli O157:H7, a human pathogen that causes diarrhea, bloody diarrhea, and the hemolytic uremic syndrome (HUS), has acquired multiple virulence factors that might aid its pathogenicity. Principal among these are the phage-encoded Shiga toxins (Stx proteins), which inhibit protein synthesis in eukaryotic cells (41), and the LEE pathogenicity island, which encodes products associated with formation of attaching-and-effacing lesions at the host surface (reviewed in reference 13). E. coli O157:H7 also has a 92-kb nonconjugative plasmid that encodes several putative virulence factors, including enterohemolysin (encoded by ehxA, also termed hlyA [1,5]), a member of the RTX family of exoproteins. E. coli O157:H7 also expresses the IrgA homologue adhesin (Iha), which was recently identified as a virulence factor in uropathogenic E. coli (16,38).Some of these factors can affect animal hosts. For example, E. coli O157:H7 causes attaching-and-effacing lesions on cultured bovine cells (31) and in neonatal calves (8). Despite this, E. coli O157:H7 is not known to cause natural disease in any host except humans. This discrepancy suggests the hypothesis that specific virulence factors of E. coli O157:H7 are regulated differently when the bacteria are in the human rather than the bovine gut. To test this hypothesis, real-time reverse transcription-PCR (RT-PCR) was employed to examine gene expression in fecal samples from children infected with E. coli O157:H7 and from experimentally infected calves. The resulting data support the hypothesis that virulence genes are differentially expressed in the human and bovine hosts.
SummaryImmune escape is considered to be the driving force behind structural variability of major antigens on the surface of bacterial pathogens, such as fimbriae. In the Dr family of Escherichia coli adhesins, structural and adhesive functions are carried out by the same subunit. Dr adhesins have been shown to bind decayaccelerating factor (DAF), collagen IV, and carcinoembryonic antigen-related cell adhesion molecules (CEACAMs). We show that genes encoding Dr adhesins from 100 E. coli strains form eight structural groups with a high level of amino acid sequence diversity between them. However, genes comprising each group differ from each other by only a small number of point mutations. Out of 66 polymorphisms identified within the groups, only three were synonymous mutations, indicating strong positive selection for amino acid replacements. Functional analysis of intragroup variants comprising the Dr haemagglutinin (DraE) group revealed that the point mutations result in distinctly different binding phenotypes, with a tendency of increased affinity to DAF, decreased sensitivity of DAF binding to inhibition by chloramphenicol, and loss of binding capability to collagen, CEACAM3 and CEACAM6. Thus, variability by point mutation of major antigenic proteins on the bacterial surface can be a signature of selection for functional modification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.